Clinical Trials Browser

Phase 1/2 × Topotecan × 30 days × Clear all

NCT07437963 2026-03-19

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

Phase 1/2 Not yet recruiting

Neuroblastoma, Ganglioneuroblastoma